Sebastian Wehle

Direktor/Vorstandsmitglied bei TIGENIX NV

Health Technology

Consumer Services

Aktive Positionen von Sebastian Wehle

Unternehmen	Position	Beginn	Ende
TIGENIX NV	Direktor/Vorstandsmitglied	15.06.2018	-

Unternehmen	Position	Beginn	Ende
TAKEDA PHARMACEUTICAL COMPANY LIMITED	Corporate Officer/Principal	-	-

University of Kiel

Doctorate Degree

International

Operativ

Director/Board Member	1
Corporate Officer/Principal	1
Doctorate Degree	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
TAKEDA PHARMACEUTICAL COMPANY LIMITED	Health Technology

Private Unternehmen	1
TiGenix NV TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium.	Health Technology

Private Unternehmen

Health Technology